Brendan P. Eckelman - May 22, 2024 Form 4 Insider Report for Inhibrx, Inc. (INBX)

Role: Chief Scientific Officer
Signature: /s/ Kelly D. Deck, as attorney in fact for Brendan P. Eckelman
Stock symbol: INBX
Transactions as of: May 22, 2024
Transactions value $: -$170,941
Form type: 4
Date filed: 5/24/2024, 06:15 PM
Previous filing: Mar 15, 2024
Next filing: May 24, 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INBX	Stock Option (right to buy)	Options Exercise	-$85.6K	-2.51K	-27.35%	$34.12	6.67K	May 22, 2024	Common Stock	2.51K	$33.63	Direct	F1
transaction	INBX	Stock Option (right to buy)	Options Exercise	-$85.3K	-2.5K	-8.57%	$34.12	26.7K	May 22, 2024	Common Stock	2.5K	$23.30	Direct	F2

Showing 1 to 2 of 2 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on January 15, 2022, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter.
F2	Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on January 3, 2024, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter.